Table 1. The effects of CA on fasting blood glucose in STZ-treated rats after treatment (n = 8).

Groups	Blood glucose (mmol/L)
	0 week	2 week	4 week	6 week	8 week
Control	5.83 ± 0.56#	6.07 ± 0.71#	6.33 ± 0.66#	6.25 ± 0.83#	6.48 ± 0.38#
Model	17.68 ± 1.59*	19.03 ± 2.01*	19.99 ± 2.14*	21.87 ± 2.41*	26.16 ± 1.42*
Model + CA (5 mg/kg)	17.14 ± 1.98*	18.46 ± 1.91*	18.85 ± 1.97*	19.02 ± 2.29*	21.23 ± 1.76*,#
Model + CA (10 mg/kg)	17.95 ± 1.83*	16.53 ± 2.08*,#	16.03 ± 1.86*,#	15.09 ± 1.69*,#	15.81 ± 2.15*,#
Model + CA (20 mg/kg)	17.46 ± 1.99*	16.17 ± 1.90*,#	15.27 ± 2.25*,#	14.32 ± 2.01*,#	13.32 ± 1.84*,#
Model + Enalapril (10 mg/kg)	18.02 ± 2.03*	18.24 ± 1.88*	18.36 ± 2.13*	20.05 ± 2.24*	24.62 ± 1.52*
CA (10 mg/kg)	5.96 ± 0.64#	5.79 ± 0.75#	6.19 ± 0.77#	6.04 ± 0.51#	6.18 ± 0.48#

^*P < 0.05 vs. control; ^#P < 0.05 vs. model.